Coronavirus: German company BioNTech says its vaccine is 90% effective

Organizers confirmed at least 10 coronavirus cases linked to the Olympics, with the two infected athletes listed as non-Japanese. Meanwhile, German experts expect a fourth wave by autumn. Follow DW for the latest.

After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.

Vaccines from both drugmakers have been approved in the EU for children from 12 to 17 years of age. Elsewhere, Australia continues its battle against the delta variant. Follow DW for the latest.

Even though vaccination rates are speeding in the US, so is the spread of the delta variant — prompting officials to reinstate some COVID restrictions previously lifted.

The Syrian province of Idlib, one of the last remaining rebel strongholds in the country's north, is experiencing a new wave of Covid-19 infections, driven by the more contagious Delta variant. This comes as the regime intensifies bombings in the region, putting local hospitals under even greater pressure. We take a closer look.

The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.

The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.

The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.

While the European Medicines Agency approved a third dose for people over 18-years-old, the agency said it was up to member states to decide whether to use them.

Russian President Vladimir Putin orders a nationwide week-long paid holiday starting on October 30 to curb Covid infections amid record coronavirus deaths.

BioNTech and Pfizer and said their vaccine is highly effective among children in the 5-11-year age group. Follow DW for the latest.

Younger people have a higher risk of heart inflammation with a Moderna shot, the country's vaccine advisory committee has said. It also advises on the BioNTech-Pfizer vaccine to all pregnant women.